Transendocardial injection of expanded autologous CD34+ cells After myocardial infarction: results of the EXCELLENT trial
Abstract
No abstract available
Author
Roncalli, Jerome
Roubille, François
Cottin, Yves
Leroux, Lionel
Mathur, Anthony
Irving, John
Khan, Sohail Q
Meneveau, Nicolas
Bresson, Didier
Hovasse, Thomas
Pompilio, Giulio
Matta, Anthony
Henon, Philippe
Trebuchet, Guillaume
de Kalbermatten, Matthieu
Garitaonandia, Ibon
Saloux, Eric
Manrique, Alain
Meyer, Nicolas
Marie, Pierre-Yves
Bhatt, Deepak L
Solomon, Scott D
Montalescot, Gilles
Newby, David E
Zannad, Faiez
Roubille, François
Cottin, Yves
Leroux, Lionel
Mathur, Anthony
Irving, John
Khan, Sohail Q
Meneveau, Nicolas
Bresson, Didier
Hovasse, Thomas
Pompilio, Giulio
Matta, Anthony
Henon, Philippe
Trebuchet, Guillaume
de Kalbermatten, Matthieu
Garitaonandia, Ibon
Saloux, Eric
Manrique, Alain
Meyer, Nicolas
Marie, Pierre-Yves
Bhatt, Deepak L
Solomon, Scott D
Montalescot, Gilles
Newby, David E
Zannad, Faiez
Date
2025-09-09
Type
Article
Subject
Myocardial infection
Collections
Citation
Roncalli J, Roubille F, Cottin Y, Leroux L, Mathur A, Irving J, Khan SQ, Meneveau N, Bresson D, Hovasse T, Pompilio G, Matta A, Henon P, Trebuchet G, de Kalbermatten M, Garitaonandia I, Saloux E, Manrique A, Meyer N, Marie PY, Bhatt DL, Solomon SD, Montalescot G, Newby DE, Zannad F; EXCELLENT Trial Investigators. Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Results of the EXCELLENT Trial. JACC Heart Fail. 2025 Nov;13(11):102626. doi: 10.1016/j.jchf.2025.102626. Epub 2025 Sep 9.
Journal / Source Title
JACC: Heart Failure
DOI
10.1016/j.jchf.2025.102626
PMID
40929748
Publisher
Elsevier
Publisher’s URL
https://www.sciencedirect.com/journal/jacc-heart-failure